Comparison of Immediate vs Deferred Cytoreductive Nephrectomy in Patients with Synchronous Metastatic Renal Cell Carcinoma Receiving Sunitinib: The SURTIME Randomized Clinical Trial

doi:10.1001/jamaoncol.2018.5543

Comparison of Immediate vs Deferred Cytoreductive Nephrectomy in Patients with Synchronous Metastatic Renal Cell Carcinoma Receiving Sunitinib: The SURTIME Randomized Clinical Trial

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	164-170
Number of pages	7
Journal	JAMA Oncology
Volume	5
Issue number	2
DOIs	https://doi.org/10.1001/jamaoncol.2018.5543
Publication status	Published - Feb 2019
Externally published	Yes

ASJC Scopus Subject Areas

Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1001/jamaoncol.2018.5543

Cite this

@article{87b3d9eea8f943928054d946c74c80ee,

title = "Comparison of Immediate vs Deferred Cytoreductive Nephrectomy in Patients with Synchronous Metastatic Renal Cell Carcinoma Receiving Sunitinib: The SURTIME Randomized Clinical Trial",

year = "2019",

month = feb,

doi = "10.1001/jamaoncol.2018.5543",

language = "English",

volume = "5",

pages = "164--170",

journal = "JAMA Oncology",

issn = "2374-2437",

publisher = "American Medical Association",

number = "2",

}

TY - JOUR

T1 - Comparison of Immediate vs Deferred Cytoreductive Nephrectomy in Patients with Synchronous Metastatic Renal Cell Carcinoma Receiving Sunitinib

T2 - The SURTIME Randomized Clinical Trial

PY - 2019/2

Y1 - 2019/2

UR - http://www.scopus.com/inward/record.url?scp=85058501248&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85058501248&partnerID=8YFLogxK

U2 - 10.1001/jamaoncol.2018.5543

DO - 10.1001/jamaoncol.2018.5543

M3 - Article

C2 - 30543350

AN - SCOPUS:85058501248

SN - 2374-2437

VL - 5

SP - 164

EP - 170

JO - JAMA Oncology

JF - JAMA Oncology

IS - 2

ER -

Comparison of Immediate vs Deferred Cytoreductive Nephrectomy in Patients with Synchronous Metastatic Renal Cell Carcinoma Receiving Sunitinib: The SURTIME Randomized Clinical Trial

ASJC Scopus Subject Areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this